Literature DB >> 208780

Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease.

B Ullman, L J Gudas, A Cohen, D W Martin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 208780     DOI： 10.1016/0092-8674(78)90122-8

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  51 in total

1.  Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.

Authors:  B Ullman; L J Gudas; S M Clift; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

2.  Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.

Authors:  S G Apasov; M R Blackburn; R E Kellems; P T Smith; M V Sitkovsky
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5'-nucleotidase (CD73).

Authors:  R Resta; S W Hooker; A B Laurent; S M Jamshedur Rahman; M Franklin; T B Knudsen; N L Nadon; L F Thompson
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

4.  A study of deoxyribonucleotide metabolism and its relation to DNA synthesis. Supercomputer simulation and model-system analysis.

Authors:  F Heinmets; R H Leary
Journal:  Cell Biophys       Date:  1991-06

Review 5.  Transmethylation in immunity and autoimmunity.

Authors:  Brian R Lawson; Theodoros Eleftheriadis; Virginie Tardif; Rosana Gonzalez-Quintial; Roberto Baccala; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2011-12-24       Impact factor: 3.969

6.  Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.

Authors:  C Justin Van De Wiele; James G Vaughn; Michael R Blackburn; Catherine A Ledent; Marlene Jacobson; Hong Jiang; Linda F Thompson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.

Authors:  M S Hershfield; N M Kredich; D R Ownby; H Ownby; R Buckley
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

8.  Metabolism and mechanism of action of 5-fluorodeoxycytidine.

Authors:  E M Newman; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

Review 9.  Metabolic defects in immunodeficiency diseases.

Authors:  A D Webster
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

10.  Deoxycoformycin: neurological toxicity.

Authors:  P P Major; R P Agarwal; D W Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.